United States· US:84148-013_52b38dd1-24bb-d9dd-e063-6394a90a00ce
5% Minoxidil Hair Growth Foam
A medicinal product containing minoxidil; niacinamide; caffeine; biotin, registered in United States by Guangzhou Ariel Biotech Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MINOXIDIL; NIACINAMIDE; CAFFEINE; BIOTIN
- Manufacturer
- Guangzhou Ariel Biotech Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11841480130160 g in 1 BOTTLE (84148-013-01)
- ndc1184148-013-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be6bb509-a726-49b6-a23a-a67d3a317079 GET /v1/drugs/be6bb509-a726-49b6-a23a-a67d3a317079?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "5; .2; .2; .3",
"substance": "MINOXIDIL; NIACINAMIDE; CAFFEINE; BIOTIN",
"productndc": "84148-013",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "g/100g; g/100g; g/100g; g/100g",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about minoxidil; niacinamide; caffeine; biotin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.